Diabetes Mellitus
Conditions
Keywords
Diabetes, Peer support, Hispanic, Latino
Brief summary
Alliance to Control Diabetes was a 2.5-year study funded by the American Academy of Family Physicians Foundation. The study was designed to help patients better manage their diabetes, and was a partnership between the Institute for Behavioral and Community Health and Clínicas de Salud del Pueblo, Inc (CDSDP), a private, non-profit corporation providing comprehensive primary care services to residents throughout Imperial and Riverside Counties, California. The investigators identified 336 patients with uncontrolled diabetes from three CDSDP clinics. Patients were randomly assigned to intervention or control conditions. The 12-month intervention consisted of individual diabetes management support delivered by a trained volunteer peer supporter. The primary aim was determine if peer support can help patients better manage their diabetes and improve the quality of their lives. Intervention effectiveness was evaluated through volunteer and patient surveys at baseline, 6 months and 12 months. This study was part of the global Peers for Progress network which has been testing peer support programs in 13 countries.
Interventions
BEHAVIORALPeer support
Sponsors
Peers for Progress
American Academy of Family Physicians
San Diego State University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Must be at least 18 years old * Must be diagnosed with Diabetes Mellitus Type I, Diabetes Mellitus Type II or Gestational Diabetes * Must be a resident of Imperial County * Must be a current patient of Clínicas de Salud del Pueblo, Inc., at one of the three participating clinics * Must speak Spanish and/or English * Must plan on remaining in Imperial County for at least 12 months after enrollment into the study
Exclusion criteria
* Must not be involved in any other diabetes-related study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in HbA1c levels. | Baseline, 6 months, 12 months | Changes in HbA1c levels of diabetes patients from baseline to 12 months as assessed by medical chart review of blood draw results. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in blood pressure. | Baseline, 6 months, 12 months | Changes in blood pressure of diabetes patients from baseline to 12 months as assessed by medical chart review. |
| Changes in cholesterol. | Baseline, 6 months, 12 months | Changes in cholesterol of diabetes patients from baseline to 12 months as assessed by medical chart review. |
| Changes in HDL, LDL and triglycerides. | Baseline, 6 months, 12 months | Changes in HDL, LDL and triglycerides of diabetes patients from baseline to 12 months as assessed by medical chart review. |
| Changes in depression. | Baseline, 6 months, 12 months | Changes in depression of diabetes patients from baseline to 12 months as assessed by self-report via interview with a trained research assistant in the participant's language of choice (Spanish or English). |
| Changes in distress. | Baseline, 6 months, 12 months | Changes in distress of diabetes patients from baseline to 12 months as assessed by self-report via interview with a trained research assistant in the participant's language of choice (Spanish or English). |
Countries
United States
Outcome results
None listed